News

Scroll back to the halcyon days of 2020, when the Internet was overflowing with self-love sermons, plus-size runway shows, and pastel infographics reminding us to “embrace every curve.” Now ...
Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...
Top Reactions for All Ages: There have been 17,021 Adverse Drug Reactions in connection with ADHD drugs/stimulants that have been reported to the FDA’s Adverse Event Reporting System (MedWatch), ...
Blockbuster weight-loss shots like Ozempic, Wegovy and Victoza may have an unexpected side effect impacting as many as ...
Such effects are temporary and will go away after a few days once your body gets used to a new prescription or dosage. However, very high doses or long-term misuse can cause irregular breathing.
St. Adalbert’s Landmarking Compromise Gets Key Approval After Years-Long Fight In Pilsen: The Pilsen church’s sanctuary won landmark approval, but other buildings on the site were not included, ...
Whether it be beer, soda or seltzer, any beverages that come in a can will likely cost Americans more after the steel and aluminum tariffs take effect. This could lead major name-brand businesses ...
The aim of the present study was to examine the effects of an 8-week heavy-resistance core strength training (HR-CST) program on upper-body strength and power performance in young athletes. The ...
Several new state laws are set to take effect in New York this month. The new laws cover a wide range of topics, including mammogram screenings for incarcerated New Yorkers, water safety education ...
A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded.